NEU — Neuren Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSuper Stock

Annual balance sheet for Neuren Pharmaceuticals, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	13.8	24.2	36.8	40.2	229
Net Total Accounts Receivable
Net Total Receivables	0.552	0.755	1.42	1.09	14.4
Prepaid Expenses
Total Other Current Assets
Total Current Assets	14.4	24.9	40	43.2	247
Net Property, Plant And Equipment	0.01	0.01	0.012	0.021	0.043
Net Intangible Assets
Other Long Term Assets
Total Assets	14.4	25	40.1	43.3	248
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.559	0.753	0.803	1.68	42.8
Total Long Term Debt
Total Debt
Total Liabilities	0.559	0.753	0.803	1.68	42.8
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	13.8	24.2	39.3	41.6	205
Total Liabilities & Shareholders' Equity	14.4	25	40.1	43.3	248
Total Common Shares Outstanding